Tempus AI (NASDAQ:TEM) Earns “Neutral” Rating from Piper Sandler

Tempus AI (NASDAQ:TEM)‘s stock had its “neutral” rating reiterated by equities research analysts at Piper Sandler in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $70.00 price objective on the stock, up from their previous price objective of $40.00. Piper Sandler’s price objective indicates a potential upside of 2.82% from the stock’s previous close.

Other analysts have also recently issued reports about the company. Bank of America cut Tempus AI from a “buy” rating to a “neutral” rating and lifted their price objective for the company from $45.00 to $60.00 in a research report on Wednesday, October 2nd. JPMorgan Chase & Co. lifted their price objective on Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and lifted their price objective for the company from $45.00 to $65.00 in a research report on Monday. Loop Capital lifted their price objective on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $54.22.

Tempus AI Stock Up 0.1 %

Tempus AI stock opened at $68.08 on Tuesday. The firm’s 50 day moving average price is $51.19. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $79.49.

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TEM. EFG Asset Management North America Corp. bought a new position in Tempus AI in the 2nd quarter valued at approximately $1,333,000. ARK Investment Management LLC bought a new position in Tempus AI in the 2nd quarter valued at approximately $18,294,000. Northwestern University bought a new position in Tempus AI in the 2nd quarter valued at approximately $491,000. Alphabet Inc. purchased a new stake in Tempus AI during the 2nd quarter valued at $54,289,000. Finally, Pier Capital LLC purchased a new stake in Tempus AI during the 2nd quarter valued at $2,301,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.